BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 30, 2009
View Archived Issues
Meta-analyses describe the effects of liraglutide in type 2 diabetes
Read More
WAY-364416 potentiates the activity of known antipsychotics, improves cognitive function
Read More
Improved endothelial function seen with insulin VIAject in type 2 diabetes
Read More
LBH-589, a promising candidate for the treatment of spinal muscular atrophy
Read More
Yuhan Research Institute discovers glucokinase activator with antidiabetes potential
Read More
RaQualia Pharma reports on novel TRPM8 antagonists as analgesic candidates
Read More
INK-055 shows promise in mouse model of collagen-induced arthritis
Read More
Champions Biotechnology signs licensing agreement with Ramot for TAR-1
Read More
FDA approves assay to aid in the diagnosis of rheumatoid arthritis
Read More
Astellas submits MAA to EMEA for telavancin for nosocomial pneumonia and cSSTI
Read More
Sanofi-aventis and Micromet sign license agreement for solid tumor BiTE antibody
Read More
Daiichi submits application to manufacture and market levofloxacin injection in Japan
Read More
Sangamo BioSciences receives CIRM award to develop ZFN-based therapy for AIDS
Read More
Cyclacel reports survival data from phase II sapacitabine trial in elderly AML patients
Read More
Ipsen's taspoglutide meets primary endpoint in Roche's first phase III trial in diabetes
Read More
Amgen reports results of third quarter of 2009
Read More
Cardiome and Astellas initiate enrollment in phase III trial of Kynapid for AF
Read More
Purinergic receptor antagonists discovered by Renovis for the treatment of pain
Read More
SYK and Janus kinase inhibitors claimed by Roche for autoimmune disorders
Read More
Wyeth discloses novel PI3K inhibitors for cancer treatment
Read More
Kowa describes new LXRbeta agonists
Read More
Paion's short-acting anesthetic/sedative CNS-7056 meets phase Ib trial endpoint
Read More
Forest Laboratories reports results from phase IIb cariprazine study in schizophrenia
Read More
AdvanDx receives FDA clearance for its 90-minute E. faecalis test
Read More
Rules-Based Medicine launches CardiovascularMAP
Read More
FDA clears D3 FastPoint L-DFA influenza A/influenza B virus identification kit
Read More
